MedTrace Logo

An Optional Two Year Follow Up Study to Study CP005A

NCT01604018 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2012-05-24

No results posted yet for this study

Summary

Cat allergy is an increasingly prevalent condition affecting 10-15% of patients with allergic rhinoconjunctivitis and/or asthma.

The purpose of this optional observational follow-on study is to further evaluate rhinoconjunctivitis symptoms on exposure to cat dander in the EEC among subjects who completed all dosing visits in study CP005 and all visits in study CP005A approximately two years after the start of treatment.

Conditions

  • Cat Allergy
  • Rhinoconjunctivitis

Sponsors & Collaborators

  • Adiga Life Sciences, Inc.

    collaborator INDUSTRY

  • Cetero Research, Toronto

    collaborator UNKNOWN

  • Circassia Limited

    lead INDUSTRY

Principal Investigators

  • Peter Couroux, MD · Cetero Research, San Antonio

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01604018 on ClinicalTrials.gov